Integrative Evaluation of Kigelia africana Fruit Extract: Broad-Spectrum Anticancer Activity, Synergism with Cisplatin and Mechanistic Insights in Colorectal Carcinoma
Molecules · 2025
DOI: 10.3390/molecules31010107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Rositsa Mihaylova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Cisplatin, Plant Extracts, Colorectal Neoplasms, Fruit. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the European Union's NextGenerationEU economic recovery package via the National Recovery and Resilience Plan of the Republic of Bu….
Abstract (Originalsprache)
Kigelia africana (“sausage tree”) is an established medicinal plant in African traditional medicine, now recognized for its diverse bioactive constituents and emerging anticancer potential. This study systematically evaluates Kigelia africana fruit extract (KAE) in an in vitro model of HT-29 colorectal carcinoma cells, focusing on its cytotoxic effects, mechanistic impact on protein expression, and synergy with cisplatin chemotherapy. Across 42 oncology-related proteins, covering cell survival, apoptosis, adhesion, invasion, and signaling, KAE demonstrated extensive but typically moderate modulation, while cisplatin produced more pronounced responses in most markers. Protein changes linked to metastasis, therapy resistance, and survival were broadly suppressed, indicating significant antitumor activity. Notably, co-treatment with KAE and cisplatin in HT-29 cells resulted in marked synergistic cytotoxicity, permitting lower cisplatin doses while maintaining efficacy. LC-HRMS analyses revealed 14 metabolites in the extract, including phenolic acids naphthoquinones and iridoids, which may contribute to these effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
- Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
- School of Life Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
ORCID-Profile: Rositsa Mihaylova, Dimitrina Zheleva-Dimitrova, Rumyana Simeonova, Georgi Momekov
Förderung
- This research was funded by the European Union's NextGenerationEU economic recovery package via the National Recovery and Resilience Plan of the Republic of Bu…
Zitieren
APA
Mihaylova, R., Bebrivenski, N., Zheleva-Dimitrova, D., Simeonova, R., Singh, N., Konstantinov, S., & Momekov, G. (2025). Integrative Evaluation of Kigelia africana Fruit Extract: Broad-Spectrum Anticancer Activity, Synergism with Cisplatin and Mechanistic Insights in Colorectal Carcinoma. Molecules. https://doi.org/10.3390/molecules31010107
Vancouver
Mihaylova R, Bebrivenski N, Zheleva-Dimitrova D, Simeonova R, Singh N, Konstantinov S, et al. Integrative Evaluation of Kigelia africana Fruit Extract: Broad-Spectrum Anticancer Activity, Synergism with Cisplatin and Mechanistic Insights in Colorectal Carcinoma. Molecules. 2025. doi:10.3390/molecules31010107
BibTeX
@article{Mihaylova2025,
author = {Mihaylova, Rositsa and Bebrivenski, Nikolay and Zheleva-Dimitrova, Dimitrina and Simeonova, Rumyana and Singh, Nisha and Konstantinov, Spiro and Momekov, Georgi},
title = {Integrative Evaluation of Kigelia africana Fruit Extract: Broad-Spectrum Anticancer Activity, Synergism with Cisplatin and Mechanistic Insights in Colorectal Carcinoma},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules31010107}
}
EUVIMED